Greg Krempl to Cisplatin
This is a "connection" page, showing publications Greg Krempl has written about Cisplatin.
Connection Strength
0.129
-
The KRAS-Variant and Cetuximab in HPV-Positive Oropharyngeal Cancer: Results from the NRG/RTOG 1016 Trial. Cancer Res Commun. 2026 Mar 01; 6(3):706-713.
Score: 0.056
-
Effect of concurrent medications on cisplatin-induced nephrotoxicity in patients with head and neck cancer. Anticancer Drugs. 2006 Feb; 17(2):207-15.
Score: 0.056
-
Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy. Laryngoscope. 2008 Aug; 118(8):1357-61.
Score: 0.017